We use cookies to enhance your experience. By clicking "Accept All," you consent to the use of cookies. Learn more
Incruse Ellipta is a prescription inhaler used to manage chronic obstructive pulmonary disease (COPD) and improve breathing. It contains umeclidinium, a long-acting bronchodilator that relaxes the muscles in the airways, helping to open them and make breathing easier.
Contains umeclidinium, a long-acting bronchodilator
Helps relieve symptoms of COPD such as shortness of breath and wheezing
Provides 24-hour symptom control with once-daily use
Easy-to-use Ellipta inhaler design for convenient daily treatment
Incruse Ellipta delivers a measured dose of umeclidinium directly to the lungs, helping to open airways and improve airflow. Regular use supports better lung function, reduces COPD symptoms, and lowers the risk of exacerbations. Proper inhaler technique ensures maximum effectiveness.
For inhalation use only. Use only as prescribed by a healthcare professional. Not suitable for people with severe allergy to umeclidinium or related medicines. Consult your doctor if symptoms persist, worsen, or if side effects occur.